Connect with us

Business

US marijuana concentrates sales aided by simpler, cheaper consumption devices

Published

on

Faced with plummeting flower prices that depressed its margins, Michigan retailer Premiere Provisions sought to put greater emphasis on the sale of concentrates.

It’s a big pivot.

Stand-alone concentrates – such as wax and shatter – were long viewed as products for hard-core cannabis consumers.

It’s a stigma that was further fueled by the need to consume them with clunky and complicated dab rigs that could easily cost north of $100 – often more than $200 – and required nails, torches and other equipment.

Premiere Provisions General Manager Edwin Maguire made sure that his dispensary in Big Rapids stocked a variety of concentrate consumption devices – from high-end table-top dab rigs for experienced concentrate consumers, to smaller, less expensive, one-click battery pens that could appeal to concentrates newbies.

Maguire said he also made sure to educate consumers about these devices and offer them at discounts.

The result has been about a 10% increase in concentrate sales from this time last year to the present, Maguire estimates.

“They are definitely a big reason our concentrate sales are up,” Maguire said of the simpler consumption devices, made by companies such as Hamilton, Lookah, Nectar Collector and Puffco.

Nationally, including medical and recreational markets, concentrate sales have jumped from some $1.9 billion in 2020 to $2.4 billion in 2022.

They are projected to reach $3.2 billion in 2024, according to the Brightfield Group, a Chicago-based cannabis analytics firm.

By educating consumers about easier-to-use concentrate-consumption devices, many retailers have been able to increase concentrate sales – an important boost at a time when flower revenue is plateauing.

Guy Rocourt, CEO of Los Angeles-based Papa & Barkley, agrees.

He said simplified concentrate-consumption tools have “tremendously” aided concentrate sales. “It’s all about normalization,” he added.

Not just for connoisseurs

Concentrates such as wax, shatter, badder and budder are, for the most part, relatively new cannabis products that started to be developed roughly 20 years ago.

Newer varieties like diamonds and crystals came onto the scene only a few years ago.

The exception is hash, which goes back thousands of years.

Only in the past five to 10 years, however, have concentrate products become ubiquitous in the nation’s dispensaries.

A big reason Premiere Provisions and other retailers have increased concentrate sales is because they have been able to un-pigeonhole concentrates as a product for connoisseurs as well as hard-core or veteran consumers.

These retailers have instead pitched concentrates as a viable option for new cannabis consumers.

“If a new person comes up to me and says, ‘How should I start?’ This is it,” Rocourt said. “Edibles take too long. Smoking flower, you might cough and get too much.”

But with concentrate consumption devices such as The Zenco, which come with tulip-shaped glass bulbs that capture the concentrate vapor when its heated, consumers can “take small sips” of concentrate vapor, appreciating the terpenes and flavonoids as if they were sipping wine.

“It has a glass that fills up with vapors, so you can drink it. That’s totally normalized. It just takes all that stigma away,” Rocourt said.

Entry devices

Lance Mathis, general manager at Inyo Fine Cannabis Dispensary in Las Vegas, agrees.

In the last year, Inyo started selling what Mathis calls “entry devices” that are typically $20 or $25.

That’s a fraction of the cost of higher end dab rigs and e-rigs, which can easily cost more than $100.

These devices are shaped like vape battery pens, except they come with a small chamber where consumers can load the concentrate, heat it, and then inhale it.

“It’s about accessibility and convenience,” Mathis said in an interview late last year.

“If it’s small and discreet and you can easily load it and play with it and not worry about spending $200 or $300 (on a more expensive device) and then not liking it.

“You can come in our shop, spend $60 and walk out with a nice gram of concentrate, a new device to play with, and you wouldn’t feel like you got burned.”

Some of the devices Inyo sells include XVape’s Cricket vaporizer for $25, and the Terp Pen for $40.

“Those devices often lead to customers becoming more serious concentrate consumers who’ll buy Puffcos for $200. Eventually they get there. You just have to give them options and the most amount of runway so that they feel comfortable,” Mathis said.

“You try to have something that’s cheap, and something that at least can get them started.”

Attitudes and normalization

These new devices are important because they also help change consumer attitudes toward concentrates, decreasing the stigma around them.

Somewhat unwieldy, dab rigs seemed specially reserved for only the heaviest cannabis and concentrate consumers.

But newer devices are sleeker, simpler, and more elegant, evoking normalcy rather than something exceptional.

“We have these great devices that normalize it,” Rocourt said.

These new devices also make it easier to switch out less appealing terms associated with concentrate and cannabis consumption – such as dabbing, vaping and smoking – for more appealing terms, such as “low temperature vaporization” or “aromatherapy.”

“When you smoke, you’re combusting it (cannabis flower) at 1,100 or 1,200 degrees, which brings all kinds of carcinogens from the plant matter. Even if you’re smoking your concentrates, you’re going to get at those levels. All kinds of weird things happen,” Rocourt said.

“But less than 500 degrees, that’s low temperature compared to combustion. That’s low temperature being causation. You could also call it aromatherapy, the notion of warming up essential oils so that they become a gas and we are smelling them for our well-being.”

Maguire notes that there are not just simpler devices, but more of then.

California-based Lookah, he noted, has put out three new concentrate and  vape batteries since the beginning of the year. These include the Seahorse, the Dragon Egg and the Unicorn.

Another product, the Fire Bee, comes with an adapter so that it can be used as a vape battery or as a concentrate-consumption device.

“With all of these devices, it’s pretty much just hitting a button,” Maguire said.

“They are also pretty affordable,” he said, adding that most Lookah products are $100 or less.

Although these devices have become more affordable, Premiere Provisions sells them at 20% off, “so it incentivizes (customers) to try out those options.”

Source: https://mjbizdaily.com/us-marijuana-concentrate-sales-climb/

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News